Should the dosage of zidovudine be adjusted in HIV-infected patients with impaired renal function?
Amantea
M A
MA
Clinical Center, National Institutes of Health, Bethesda, MD 20892.
D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D015215:Zidovudine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
D015215:Zidovudine